In a previous post, I examined the awards made as part of the American Recovery and Reinvestment Act (ARRA) and sorted them according whether these awards were made to investigators who had other funding in FY2008 ("Existing") or to investigators who did not have funding in FY2008 ("New"). I have now repeated the analysis in terms of investigators rather than awards, have examined the funding status of these investigators prior to receiving ARRA funding in a more refined way, and have investigated the funding status of the investigators subsequent to FY2010 when ARRA funding terminated.
The key results from this analysis are as follows:
5182 investigators received 1 or more non-supplemental ARRA award.
2526 were funded with some NIH in FY2008
449 were funded in FY2007 but not FY2008
273 were funded in FY2006 but not 2007 or 2008
1934 were not funded in FY2006, FY2007, or FY2008. Some of these appear to be "New Investigators" by the NIH definition while others either have had R-mechanism funding in the past or have been funded by other NIH mechanisms.
Further examination of these groups revealed a substantial difference in the mechanisms by which these investigators were funded with ARRA funds.
More than 40% of the investigators who had been funded in FY2006, FY2007, or FY2008 received an R01 award through ARRA. The majority of these are likely 2-year R01s although the distribution of these awards between 2-year R01s and longer R01s with additional years funded through non-ARRA funds was not investigated further. In contrast, less than 20% of the awards to investigators who had no R-funding from FY2006-FY2008 were R01s. Instead, this group of investigators were funded through a mixture of mechanisms with smaller budgets including R21s, R03s, and R15s. The fraction of ARRA-specific RC1 ("Challenge Grants") and RC2 ("Grand Opportunity Grants") was approximately the same across all four groups.
With these lists of investigators available, it was possible to examine funding subsequent to ARRA. Overall, 2418 of the 5182 investigators were funded in FY2011 (47%). This breaks down as follows:
1760 of 2526 investigators who were funded in FY2008 (70%)
174 of 449 investigators who were funded in FY2007 (but not FY2008) (39%)
88 of 273 investigators who were funded in FY2006 (but not FY2008 or FY2007) (32%)
396 of 1934 investigators who were not funded in FY2008, FY2007, or FY2006 (20%)
In FY2012, 2532 ARRA funded investigators were now funded with 2109 of those also funded in FY2011, 423 newly funded in FY2012, and 309 funded in FY2011 but not FY2012.
This analysis reveals approximately 60% of the non-supplemental ARRA awards went to investigators who were already funded or had been recently funding prior to ARRA while approximately 40% of these awards went to investigators with no recent history of R-mechanism funding. Of the later group, about 20% were refunded in FY2011. About 9% of this group were refunded in FY2012.